Match!
Conor Farrington
University of Cambridge
EconomicsPregnancyInsulinType 1 diabetesMedicine
30Publications
8H-index
189Citations
What is this?
Publications 39
Newest
#1Conor Farrington (University of Cambridge)H-Index: 8
#2Roman Hovorka (University of Cambridge)H-Index: 49
Last. Helen R. Murphy (University of Cambridge)H-Index: 27
view all 3 authors...
BACKGROUND: Clinicians mediate access to closed-loop technology for people with diabetes. Consequently their attitudes regarding appropriate levels of closed-loop usage will play a key role in futu...
Source
#1Conor Farrington (University of Cambridge)H-Index: 8
#2Helen R. Murphy (UEA: University of East Anglia)H-Index: 27
Last. Roman Hovorka (Medical Research Council)H-Index: 49
view all 3 authors...
Source
#1Julia Lawton (Edin.: University of Edinburgh)H-Index: 38
#2Maxine Blackburn (Edin.: University of Edinburgh)H-Index: 3
Last. David W. H. Rankin (Edin.: University of Edinburgh)H-Index: 30
view all 6 authors...
Background While a growing body of research has explored why people take part in clinical trials, this research has not considered how people’s understandings, motivations and agendas might influence their conduct during a trial. This is an important area of enquiry because it is now widely recognised that an intervention might lead to different clinical outcomes when delivered as part of a trial than when implemented in routine clinical practice; however, the reasons for this are not fully unde...
Source
Source
#1Julia Lawton (Edin.: University of Edinburgh)H-Index: 38
#2Maxine Blackburn (Edin.: University of Edinburgh)H-Index: 3
Last. Nina Hallowell (University of Oxford)H-Index: 32
view all 7 authors...
AbstractIncreasing ethical attention and debate is focusing on whether individuals who take part in clinical trials should be given access to post-trial care. However, the main focus of this debate...
Source
#1Conor Farrington (University of Cambridge)H-Index: 8
#2Zoe A. Stewart (University of Cambridge)H-Index: 2
Last. Helen R. Murphy (UEA: University of East Anglia)H-Index: 27
view all 4 authors...
Aims:Closed-loop insulin delivery has the potential to improve day-to-day glucose control in type 1 diabetes pregnancy. However, the psychosocial impact of day-and-night usage of automated closed-loop systems during pregnancy is unknown. Our aim was to explore women’s experiences and relationships between technology experience and levels of trust in closed-loop therapy.Methods:We recruited 16 pregnant women with type 1 diabetes to a randomized crossover trial of sensor-augmented pump therapy com...
1 CitationsSource
#1Yolande E. Chan (Queen's University)H-Index: 22
#2Conor Farrington (University of Cambridge)H-Index: 8
Abstract Many universities are disengaged from their local regions. While universities are hotbeds of knowledge with the potential to generate new and disruptive technologies, their development strategies and public relations engagements rarely emphasize the potential of universities to act as local and regional economic engines. Similarly, information systems (IS) and other scholars generally aim to make international, not local impacts. Local contributions are often viewed as distractions from...
Source
#1Zoe A. Stewart (Medical Research Council)H-Index: 4
#2Malgorzata E. Wilinska (Medical Research Council)H-Index: 10
Last. Helen R. MurphyH-Index: 27
view all 10 authors...
OBJECTIVE Despite advances in technology, optimal glucose control remains elusive and neonatal complications remain ubiquitous in type 1 diabetes (T1D) pregnancy. Our aim was to examine the safety, efficacy, and longer-term feasibility of day-and-night closed-loop insulin delivery. RESEARCH DESIGN AND METHODS We recruited 16 pregnant women (mean [SD]: age 32.8 [5.0] years, T1D duration 19.4 [10.2] years, HbA 1c 8.0% [1.1], and BMI 26.6 [4.4] kg/m 2 ) to an open-label, randomized, crossover trial...
21 CitationsSource
#1Zoe A. Stewart (Medical Research Council)H-Index: 4
#2Jennifer M. Yamamoto (U of C: University of Calgary)H-Index: 5
Last. Helen R. Murphy (UEA: University of East Anglia)H-Index: 27
view all 7 authors...
Abstract Tight glucose control during labor and delivery is recommended for pregnant women with type 1 diabetes. This can be challenging to achieve using the current treatment modalities. The autom...
4 CitationsSource
#1Zoe A. StewartH-Index: 2
Last. Helen R. MurphyH-Index: 27
view all 10 authors...
OBJECTIVE Despite advances in technology, optimal glucose control remains elusive and neonatal complications ubiquitous in type 1 diabetes (T1D) pregnancy. Our aim was to examine the safety, efficacy, and longer-term feasibility of day-and-night closed-loop insulin delivery. RESEARCH DESIGN AND METHODS We recruited 16 pregnant women (mean [SD]: age 32.8 [5.0] years, T1D duration 19.4 [10.2] years, HbA1c 8.0% [1.1%], BMI 26.6 [4.4] kg/m2) to an open-label, randomized, crossover trial. Participant...
1234